News Medical on MSN21h
Microglia reprogramming offers novel strategy to combat melanoma brain metastases
Brain metastases are one of the most severe complications of melanoma, the most aggressive type of skin cancer. Researchers ...
Co-located cell types help drive aggressive brain tumors, study finds
A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, ...
precisionmedicineonline16h
Immuneering Partners with Regeneron to Study Combined MEK, PD-1 Inhibitor Therapy in Solid Tumors
NEW YORK – Immuneering on Thursday said it signed a clinical supply agreement with Regeneron to obtain the anti-PD-1 therapy Libtayo (cemiplimab) for a Phase IIa trial testing Immuneering's MEK ...